First Allied Advisory Services Inc. grew its position in shares of Stryker Co. (NYSE:SYK) by 2.7% during the 1st quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 17,148 shares of the medical technology company’s stock after buying an additional 448 shares during the quarter. First Allied Advisory Services Inc.’s holdings in Stryker were worth $3,404,000 as of its most recent filing with the Securities & Exchange Commission.
Several other institutional investors have also recently bought and sold shares of SYK. ERTS Wealth Advisors LLC purchased a new stake in shares of Stryker during the 4th quarter worth approximately $25,000. Northwest Wealth Management LLC grew its stake in Stryker by 103.6% in the 4th quarter. Northwest Wealth Management LLC now owns 169 shares of the medical technology company’s stock valued at $26,000 after buying an additional 86 shares in the last quarter. Semmax Financial Advisors Inc. purchased a new position in Stryker in the 4th quarter valued at approximately $28,000. Horan Securities Inc. purchased a new position in Stryker in the 4th quarter valued at approximately $30,000. Finally, Truehand Inc purchased a new position in Stryker in the 4th quarter valued at approximately $30,000. 74.71% of the stock is currently owned by hedge funds and other institutional investors.
Stryker stock opened at $184.18 on Wednesday. The company has a quick ratio of 1.30, a current ratio of 2.12 and a debt-to-equity ratio of 0.68. The firm has a market capitalization of $68.73 billion, a price-to-earnings ratio of 25.20, a price-to-earnings-growth ratio of 2.24 and a beta of 0.84. Stryker Co. has a twelve month low of $144.75 and a twelve month high of $199.85.
Stryker (NYSE:SYK) last posted its quarterly earnings results on Tuesday, April 23rd. The medical technology company reported $1.88 earnings per share for the quarter, topping the consensus estimate of $1.84 by $0.04. The business had revenue of $3.52 billion during the quarter, compared to the consensus estimate of $3.51 billion. Stryker had a net margin of 25.38% and a return on equity of 26.72%. The firm’s revenue for the quarter was up 8.5% on a year-over-year basis. During the same period in the previous year, the firm posted $1.68 earnings per share. On average, equities analysts anticipate that Stryker Co. will post 8.15 EPS for the current fiscal year.
The firm also recently declared a quarterly dividend, which will be paid on Wednesday, July 31st. Shareholders of record on Friday, June 28th will be paid a $0.52 dividend. This represents a $2.08 annualized dividend and a yield of 1.13%. The ex-dividend date is Thursday, June 27th. Stryker’s dividend payout ratio is presently 28.45%.
A number of research firms recently weighed in on SYK. Deutsche Bank lifted their price objective on shares of Stryker from $181.00 to $208.00 and gave the company a “buy” rating in a research note on Wednesday, April 24th. Robert W. Baird lifted their price objective on shares of Stryker from $201.00 to $206.00 and gave the company an “outperform” rating in a research note on Wednesday, April 24th. Zacks Investment Research downgraded shares of Stryker from a “buy” rating to a “hold” rating in a report on Tuesday. Canaccord Genuity raised their price target on shares of Stryker from $190.00 to $195.00 and gave the company a “buy” rating in a report on Wednesday, April 24th. Finally, Oppenheimer raised their price target on shares of Stryker from $183.00 to $192.00 and gave the company an “outperform” rating in a report on Wednesday, April 24th. Seven research analysts have rated the stock with a hold rating and sixteen have assigned a buy rating to the stock. Stryker currently has a consensus rating of “Buy” and a consensus target price of $196.89.
In other Stryker news, VP Yin C. Becker sold 15,240 shares of the business’s stock in a transaction on Thursday, March 21st. The shares were sold at an average price of $198.03, for a total value of $3,017,977.20. Following the completion of the sale, the vice president now directly owns 16,577 shares of the company’s stock, valued at $3,282,743.31. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CFO Glenn S. Boehnlein sold 2,700 shares of the business’s stock in a transaction on Wednesday, May 8th. The stock was sold at an average price of $188.21, for a total transaction of $508,167.00. Following the completion of the sale, the chief financial officer now directly owns 23,333 shares of the company’s stock, valued at $4,391,503.93. The disclosure for this sale can be found here. Insiders sold 111,550 shares of company stock valued at $21,374,171 over the last three months. 7.20% of the stock is currently owned by insiders.
ILLEGAL ACTIVITY NOTICE: “Stryker Co. (SYK) Holdings Boosted by First Allied Advisory Services Inc.” was reported by The Lincolnian Online and is owned by of The Lincolnian Online. If you are reading this story on another publication, it was illegally stolen and reposted in violation of international copyright and trademark law. The correct version of this story can be viewed at https://www.thelincolnianonline.com/2019/05/15/stryker-co-syk-holdings-boosted-by-first-allied-advisory-services-inc.html.
Stryker Company Profile
Stryker Corporation operates as a medical technology company. The company operates through three segments: Orthopaedics, MedSurg, and Neurotechnology and Spine. The Orthopaedics segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. The MedSurg segment offers surgical equipment and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, and other medical devices for use in various medical specialties.
Recommended Story: Balance Sheet
Want to see what other hedge funds are holding SYK? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Stryker Co. (NYSE:SYK).
Receive News & Ratings for Stryker Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stryker and related companies with MarketBeat.com's FREE daily email newsletter.